Distress, not low libido alone, defines HSDD, which requires a biopsychosocial evaluation, according to Holly N. Thomas, MD, MS.
|Articles|July 27, 2015
VIDEO: Research Primer on Mammographic Density
Animation and time-lapse imaging combines with storytelling to examine the relationship between breast cancer risk and the biology of breast density. From the University of California Television (UCTV), part of their Breast Cancer Prevention and Treatment series.
Advertisement
Animation and time-lapse imaging combines with storytelling to examine the relationship between breast cancer risk and the biology of breast density. From the
This video is part of the
Advertisement
Related to this article
Perimenopausal women over-reported total sleep time by a mean of 35.3 minutes and under-reported wake time compared with Fitbit data.
Elinzanetant cut moderate-to-severe VMS frequency by ≥50% in 66.9% of US participants compared with 40.5% on placebo.
Open-ended questions help ob-gyns untangle GSM and low desire and build adherence-focused treatment plans, according to Sheryl Kingsberg, PhD.
A systematic review found transdermal nitroglycerin may modestly reduce hot flashes, but evidence remains limited.
The FDA approved the first generic of Climara Pro, a weekly estradiol/levonorgestrel patch for VMS and osteoporosis prevention in women with a uterus.
The investigational Evident test requires 3 tumor markers on the same extracellular vesicle to flag early-stage ovarian cancer.
The Menopause Society's 2026 meeting in San Diego will tackle estrogen avoidance, cancer survivorship, mood, and sleep.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Before Pregnancy Begins: Why the Timing of Carrier Screening Matters
2
FDA approves first generic estradiol/levonorgestrel weekly patch
3
Executive order directs NIH to create women's health division
4
What to expect at The Menopause Society's 2026 Annual Meeting
5